Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma

Virchows Archiv

Volumn 439, Issue 5, 2001, Pages 628-635

  Döme, Balázs ^b   Somlai, Beáta ^c   Ladányi, Andrea ^a   Fazekas, Károly ^a   Zöller, Margot ^d   Tímár, József ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CD44v3; Immunohistochemistry; Malignant melanoma; Metastasis; MMP2; RT PCR

Indexed keywords

CD44V ANTIGEN; GELATINASE A; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL POPULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 0035166482     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100451     Document Type: Article

References (44)

1. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor
2. Molecular pathology of melanoma
3. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin
4. A low NM23.H1 gene expression identifying high malignancy human melanomas
5. Pathology of malignant melanoma, including new markers and techniques in diagnosis and prognosis
6. The cell surface glycoprotein CD44 has been implicated in the progression and metastasis of certain human tumours including malignant melanoma (MM)
7. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival
8. Expression of NM23 in human mela-noma progression and metastasis
9. CD44 and melano-cytic tumors: A possible role for standard CD44 in the epider-motropic spread of melanoma
10. Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression
11. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms
12. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
13. CD44 expression in melanocytic lesions: A marker of malignant progression?
14. Human melanoma: Development and progression
15. Matrix metalloproteinases in human melanoma
16. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon
17. Expression of the nm23 metastasis-suppressor gene product in skin tumors
18. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
19. Working experience with a new vacuum-accelerated microwave histoprocessor
20. Sex-dependent liver metastasis of human melanoma lines in SCID mice
21. Selection and characterization of human melanoma lines with different liver-colonizing capacity
22. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
23. Expression of CD44 splice variants in human cutaneous melanoma and mel-anoma cell lines is related to tumor progression and metastatic potential
24. Melanoma-mediated dissolution of extra-cellular matrix: Contribution of urokinase-dependent and me-talloproteinase-dependent proteolytic pathways
25. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohisto-chemical study
26. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin
27. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay
28. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: An immunohistological assessment in human skin
29. CD44 and variants in melanocytic skin neoplasms
30. CD44 standard and variant isoform expression in normal human skin appendages and epidermis
31. Expression of CD44 variant isoforms in malignant melanoma
32. Expression of CD44 isoforms in human skin cancer
33. Cell-matrix interactions during tumor invasion
34. Extra-cellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
35. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells
36. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta
37. Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern
38. The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells
39. Transforming growth factors produced by certain human tumor cells: Poly-peptides that interact with epidermal growth factor receptors
40. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
41. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
42. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met
43. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium
44. Localization of matrix metallo-proteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion